Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-511528-15-00Phase 4Completed
Phase 4, randomised trial of levobupivacaine in hip fracture (2 arms), sponsored by Asociación Gallega de Anestesiología, Reanimación y Terapéutica del Dolor. Primary endpoint: Primary: Analgesic efficacy and safety via VAS at 2 hours postoperatively. Started Jun 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-511528-15-00.